Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, Neal Shore, J Alfred Witjes, Gary Steinberg, Jens Bedke, Hiroyuki Nishiyama, Xiao Fang, Ritesh Kataria, Eric Sbar, Xieyang Jia & Arlene Siefker-Radtke
Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Stacey L. Amorosi, Neal D. Shore
Andrew J. Armstrong, Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, Boris Alekseev, Taro Iguchi, Francisco Gomez-Veiga, Brad Rosbrook, Ho-Jin Lee, Gabriel P. Haas, and Arnulf Stenzl
Elisa M. Ledet PhD, Earle F. Burgess MD, Alexandra O. Sokolova MD, Ellen B. Jaeger BS, Whitley Hatton MS, Marcus Moses MS, Patrick Miller MPH, Patrick Cotogno MS, Jodi Layton MD, Pedro Barata MD, Brian E. Lewis MD, Mari Nakazawa MD, Jason Zhu MD, Beth Dellinger MS, Sara Elrefai MD, Nellie N. Nafissi MD, Jan B. Egan PhD, Neal Shore MD, Rana R. McKay MD, Alan H. Bryce MD, Heather H. Cheng MD, PhD, Emmanuel S. Antonarakis MD, Oliver Sartor MD
Fred Saad, Kim N. Chi, Neal D. Shore, Julie N. Graff, Edwin M. Posadas, Jean-Baptiste Lattouf, Byron M. Espina, Eugene Zhu, Alex Yu, Anasuya Hazra, Marc De Meulder, Rao N. V. S. Mamidi, Branislav Bradic, Peter Francis, Vinny Hayreh & Arash Rezazadeh Kalebasty
Abhishek Srivastava & Neal D. Shore
Fred Saad, Martin Bögemann, Kazuhiro Suzuki & Neal Shore
Daniel E. Spratt, Neal Shore, Oliver Sartor, Dana Rathkopf & Kara Olivier
Dr. Shore, an expert in urologic oncology, discusses hormonal therapy in prostate cancer. He leads an educational discussion and course on prostate cancer for learning clinicians. The activity has been designed to meet the educational needs of oncologists, urologists, advanced practice clinicians, and other professionals involved in the management of patients with prostate cancer.
For clinicians to access the course use the link below to access the course and begin the pre-test. In order to receive CME credit, participants must view the activity and complete the post-test and evaluation form.
Key Issues For The Advanced Bladder Cancer Clinic: Incorporating Immunotherapy Into Your Community-Based Urology Practice
Join Dr. Neal Shore and his esteemed colleagues for this four-part webinar series focused on the implementation of IO, as well as other recently approved advanced bladder cancer therapies. This series was designed for all clinicians interested in bladder cancer treatment, but especially for those dedicated community urology practices desiring to establish an advanced bladder cancer clinic of excellence.
Earn 1.0 Credit hours (ACCME/ACPE/ANCC) for each webinar.
For clinicians, to view the interactive webinars, click the link below and choose which webinar you would like to begin. Then log in or register to gain access and begin the course.
- Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
- Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
- Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
- Comparison of Germline Mutations In African American And Caucasian Men With Metastatic Prostate Cancer